| ASSET | YEARS | % RETURN |
|---|---|---|
QXO (QXO) | 2004-2022 | 9,370,550% |
Supernus Pharmaceuticals (SUPN) | 2004-2022 | 8,437,900% |
OPTIMIZERx (OPRX) | 2004-2022 | 8,399,900% |
Mesoblast (MESO) | 2004-2022 | 5,819,900% |
Cenntro Electric (CENN) | 2004-2022 | 5,764,092.14% |
Expedia (EXPE) | 2004-2022 | 2,973,403.45% |
Avita Medical (RCEL) | 2004-2022 | 1,649,900% |
Akari Therapeutics (AKTX) | 2004-2022 | 1,503,900% |
FingerMotion (FNGR) | 2004-2022 | 1,404,900% |
Northern Oil & Gas (NOG) | 2004-2022 | 1,037,779.17% |
Evogene (EVGN) | 2004-2022 | 999,900% |
Danaos (DAC) | 2004-2022 | 734,915% |
MDxHealth (MDXH) | 2004-2022 | 734,344.44% |
Addex Therapeutics (ADXN) | 2004-2022 | 699,900% |
MiMedx (MDXG) | 2004-2022 | 694,900% |
Altimmune (ALT) | 2004-2022 | 567,141.38% |
Lexaria Bioscience (LEXX) | 2004-2022 | 550,646.27% |
Ridgetech (RDGT) | 2004-2022 | 488,081.82% |
Green Brick Partners (GRBK) | 2004-2022 | 474,998.04% |
Scienture (SCNX) | 2004-2022 | 472,995.98% |
Addentax (ATXG) | 2004-2022 | 459,328.57% |
Oramed Pharmaceuticals (ORMP) | 2004-2022 | 386,624.14% |
INVO Fertility (IVF) | 2004-2022 | 381,500.01% |
Xcel Brands (XELB) | 2004-2022 | 350,000% |
Fubotv (FUBO) | 2004-2022 | 347,900% |
